Clinical Report: Association Between Starting Psychotherapy and Reduction of Psychotropic Medication Use

Overview

This study evaluates the impact of initiating psychotherapy on psychotropic medication use over a ten-year period.

Background

The increasing use of psychotropic medications raises concerns regarding long-term safety and treatment complexity in mental health care. Psychotherapy has established efficacy in treating mental health disorders, yet its role in optimizing medication use remains underexplored.

Data Highlights

Key Findings

• The median number of psychotropic medications decreased from 5 to 2 (p < 0.001).
• Total Defined Daily Dose remained stable at approximately 21.7 (p = 0.999).
• Benzodiazepine use declined from 87.6% to 67.5% (p < 0.001).
• Antidepressant use decreased from 81.8% to 68.8% (p < 0.001).
• Men were more likely than women to discontinue benzodiazepines (odds ratio 1.27, 95% CI 1.13–1.43).
• Reduction in benzodiazepine use was greatest in patients with depressive, personality, and episodic mood disorders.

Clinical Implications

The initiation of psychotherapy may facilitate a significant reduction in the complexity of psychotropic medication regimens without increasing overall dosage. This finding supports the integration of psychotherapy into treatment plans for patients on psychotropic medications.

Conclusion

The study demonstrates that starting psychotherapy is associated with a reduction in psychotropic medication use.

Related Resources & Content

1. Drugs - Real World Outcomes, 2016 -- Long-Term Continuation of Antipsychotic Therapy in Older Adults with Dementia: A Retrospective Cohort Analysis from a Population Perspective
2. BMC Psychiatry (Springer), 2026 -- Analysis of Sick Leave Trends Before and After Initiation of Psychological Treatment in Patients with Common Mental Disorders: A Quasi-Experimental Study Utilizing Registry Data
3. BMC Psychiatry (Springer), 2025 -- The Use of Psychotropic Medications Among Patients with Autism Spectrum Disorder
4. Drugs - Real World Outcomes, 2023 -- Association Between Psychoactive Medication Use and Suicide Risk in Individuals Aged 75 and Older: A Comprehensive Population Analysis
5. Overview | Depression in adults: treatment and management | Guidance | NICE, 2026
6. VA/DoD 2023 Clinical Practice Guideline for the Management of PTSD - PTSD: National Center for PTSD
7. Overview | Depression in adults: treatment and management | Guidance | NICE
8. VA/DoD 2023 Clinical Practice Guideline for the Management of PTSD - PTSD: National Center for PTSD
9. Deprescribing Electronic Decision Support for Adults Living in Long-Term Care